Capital Raise

Patriot National Bancorp (PNBK) completed a registered direct offering, raising $10.65 million through the issuance of common stock. This follows a previous $50 million private placement, bolstering investor confidence in Patriot Bank’s growth. The offering strengthens the bank’s capital base, enabling it to execute its strategic vision. Performance Trust Capital Partners, LLC, Blank Rome LLP, and Robinson & Cole LLP advised on the offering.

Senseonics Holdings raised $77.8 million via a public offering (115M shares at $0.50) and a $20.3M private placement from Abbott Laboratories, which acquired a 4.99% stake. The funds will accelerate U.S. commercialization of its Eversense 365, a 12-month implantable glucose monitor, and support innovation. While the capital extends operations through 2026, significant share dilution and low pricing reflect market skepticism. Abbott’s investment signals strategic interest in implantable CGM tech, despite maintaining dominance with its FreeStyle Libre system. Key challenges include securing Medicare coverage and expanding beyond niche medical markets.